The Effects Of Spirulina Platensis On Anthropometric Indices, Appetite, Lipid Profile And Serum Vascular Endothelial Growth Factor (VEGF) In Obese Individuals: A Randomized Double Blinded Placebo Controlled Trial

Effect None
Values ng/l. Mean and SD. Placebo: before 3.20 ± 0.28, after 3.21 ± 0.29. Spirulina: before 3.22 ± 0.37, after 3.22 ± 0.37.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 64
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 64 obese participants took 2 g of spirulina platensis or placebo daily for 12 weeks.

The primary outcome was LDL and there wasn't a difference between groups. There was a greater reduction in weight, waist circumference, BMI, and appetite in the spirulina group, while there weren't differences in VEGF, triglycerides, HDL, or total cholesterol.

The study was prepregistered IRCT2015071219082N7